Darolutamide with androgen deprivation therapy recommended for treating hormone-relapsed non-metastatic prostate cancer

People taking the combination treatment have more time before their prostate cancer spreads compared with androgen deprivation therapy alone, says NICE guidance.

Please sign in or register for FREE

No comments yet.